INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
03/18/2026
Back to search
Official data from USPTO
SOTIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
SOTIO
ST13
US500000079218559Class
5, 42, 44
Filing
79218559
Registration
5577770
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
60
Latest update
03/19/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 42, 44
Filing date
08/10/2017
Registration date
10/09/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/18/2025
Last transaction
03/19/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CZ
Examiner
BENMAMAN, ALICE
Current location
Historical data usage
Holders and representatives
Holders
S. A. (pessoa física)
S. A. (pessoa física)
Representatives
Shane Rumbaugh Rumbaugh Law PLLC
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalsmedical and veterinary preparations for the treatment of oncologicalimmune and autoimmune diseases; anticancer preparations; antitumor drugs; vaccines; anticancer vaccines; synthetic peptidesrecombinant proteinsantibodiesantibody derivativesantibody-drug conjugatesnucleotides and nucleotide analogs all for the treatment of oncologicalimmune and autoimmune diseases for medical and veterinary purposes; biological preparations for the treatment of oncologicalimmune and autoimmune diseases for medical and veterinary purposes; cellular preparations for the treatment of oncologicalimmune and autoimmune diseases for medical and veterinary purposes ; biological tissue from blood or bone marrow intended for subsequent implantation; radiopharmaceutical preparations for diagnosticmedical and veterinary use; pharmaceutical preparations for the treatment of autoimmune diseases and diabetes; clinical diagnostic reagents for medical or veterinary purposes; diagnostic agentspreparations and diagnostic kits comprised of medical diagnostic reagentssample collection devices in the nature of specimen cups and tubesinstructions for testing of bodily fluids and tissues for use in testing and detection of oncologicalimmune or autoimmune diseases for medical and veterinary purposes; drug delivery agents in the form of dissolvable tabletscapsulesgelsmicellesliposomesparticlesnanoparticlesointment and creamsthat facilitate the delivery of pharmaceutical preparations; adjuvants for medical use; dietetic substances adapted for medical usefood and beverages
Class 42
Scientific servicesresearch and design in the field of antineoplastic and immunomudulating agents relating thereto; industrial analysis and research services in the field of pharmaceuticals and biotechnology; scientific research for medical and veterinary purposes in the field of oncologicalimmune and autoimmune diseases ; scientific research and development for medical and veterinary purposes in the area of cancerous diseasesautoimmune diseases or diabetes; pharmaceutical drug development services; conducting clinical trials for others; preclinical and clinical research in the field of oncologicalimmune and autoimmune diseases; analysis of toxicology and mode of action of biologicalschemicals and combinations on animalstoxicology services; pharmaceutical and biological product researchdevelopmentsafetyefficacy and quality control testing services; scientific research and development for diagnostic purposes ; computer-aided diagnostic testing servicesproviding reagent sample testing and diagnostic services for others in the fields of science and research related thereto; design and development of computer software and databases; design and development of computer software and databases for logisticssupply chain management and laboratory management in the fields of oncology and autoimmune disease and cancer and autoimmune research
Class 44
Medical services; medical diagnostic services for diagnostic or treatment purposes
Publications
History of USPTO decisions and trademark events.
60 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/05/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
07/18/2025
71AG
REGISTERED-SEC.71 ACCEPTED
07/18/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/14/2025
ES71
TEAS SECTION 71 RECEIVED
04/09/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/16/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/16/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/16/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/09/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/18/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/20/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/20/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/20/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/20/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/20/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
02/11/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/03/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/03/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/03/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/03/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/03/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/21/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/18/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/18/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/15/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/24/2019
FIMP
FINAL DISPOSITION PROCESSED
01/24/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/09/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/27/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
10/09/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/24/2018
PUBO
PUBLISHED FOR OPPOSITION
07/24/2018
GPNX
NOTIFICATION PROCESSED BY IB
07/20/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/04/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/04/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/04/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/21/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/15/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
06/15/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/15/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
06/15/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/15/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/06/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/06/2018
ALIE
ASSIGNED TO LIE
06/01/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/29/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/22/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/22/2018
RFNT
REFUSAL PROCESSED BY IB
12/17/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/27/2017
RFRR
REFUSAL PROCESSED BY MPU
11/27/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/14/2017
CNRT
NON-FINAL ACTION WRITTEN
11/13/2017
DOCK
ASSIGNED TO EXAMINER
11/13/2017
MAFR
APPLICATION FILING RECEIPT MAILED
10/24/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/20/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/19/2017
Continuous trademark protection
Get notified about every new filing that threatens SOTIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.